OM:VITRBiotechs
Vitrolife (OM:VITR) Q4 Loss Of SEK 5.3b Tests Bullish Turnaround Narratives
Vitrolife FY 2025 earnings snapshot
Vitrolife (OM:VITR) closed FY 2025 with fourth quarter revenue of SEK 892 million and a loss per share of SEK 39.23, as net income excluding extra items came in at a loss of SEK 5,313 million. Over the past year, the company has seen quarterly revenue range from SEK 835 million to SEK 892 million, while EPS moved from SEK 1.03 in Q4 2024 to SEK 0.74 in Q2 and Q1 2025, before swinging to a loss in Q4. For investors, the headline story is that solid top line...